| Old Articles: <Older 481-490 Newer> |
 |
BusinessWeek September 27, 2004 Kerry Capell |
How Dublin Keeps Big Pharma Happy By providing cheap yet educated workers and giving tax breaks to big investors, the Irish have turned their country into a major drug manufacturing center.  |
BusinessWeek September 27, 2004 Gene G. Marcial |
Looking Way Past Vodka In Poland Based in Warsaw, Central European Distribution's NASDAQ-traded stock is on the rise in a soggy market, up from 18.74 in May to 23.31 a share.  |
The Motley Fool September 16, 2004 Seth Jayson |
Success Can Be Bitter, Apple A U.K. consumer watchdog office is investigating claims of Apple's unfair pricing practices.  |
The Motley Fool September 16, 2004 Wherrett & Yelovich |
Nokia Goes Nano The telecom giant strikes a deal to use Kopin's display nanotechnology.  |
InternetNews September 15, 2004 Roy Mark |
Infineon Pleads Guilty to DRAM Price-Fixing The German chipmaker agrees to $160M fine... Other DRAM manufacturers under investigation, the DOJ says.  |
The Motley Fool September 15, 2004 Rich Smith |
Russia Combines Oil and Gas Gazprom and Rosneft will merge and trade freely, but rather than being tempted to buy into the rapidly appreciating Gazprom, investors should consider sitting this oil rush out.  |
The Motley Fool September 13, 2004 Rich Smith |
Russian Bear Gains Weight Despite a spate of bad news, Russia's economy continues to grow. By buying into some gold-standard U.S. companies, an investor can partake of Russia's growth while considerably limiting the risk of suffering a "YUKOS."  |
BusinessWeek September 20, 2004 Matlack & Holmes |
Boeing vs. Airbus: It's Getting Ugly The two planemakers are raising the volume of their spat over subsidies. Will the dispute go to the WTO?  |
BusinessWeek September 20, 2004 Stanley Reed |
Will Cazenove Be A Blushing Bride? Short of capital, the venerable City firm is exploring a union with a big bank.  |
The Motley Fool September 10, 2004 Alyce Lomax |
Next Stop, OracleSoft? Nope -- Oracle still has plenty of hurdles ahead, including possible scrutiny from the European Union.  |
| <Older 481-490 Newer> Return to current articles. |